The role of histologic grading in the prognosis of patients with carcinoma of the breast
- 1 November 1997
- Vol. 80 (9) , 1708-1716
- https://doi.org/10.1002/(sici)1097-0142(19971101)80:9<1708::aid-cncr3>3.0.co;2-a
Abstract
Quantified grading of breast carcinoma through histologic analysis has been practiced for many years, but generally has not been used as an aid in treatment decision-making. A representative sample of the literature is reviewed and discussed. The literature overwhelmingly confirms that histologic features suitable for grading provide important prognostic information at all stages of the disease, but there is no uniformly agreed on methodology for the application of this information. Disagreement still exists as to its validity and it is often ignored. It appears reasonable that serious attempts be made to overcome the perceived problems with the grading of breast carcinoma and to develop a consensus regarding a methodology for quantifying this well established index of the virulence of the disease that is comparable to the consensus reached in the American Joint Committee on Cancer staging of the extent of disease. This information then could be used in the design of clinical trials. [See editorial counterpoint on pages 1703-5 and reply to counterpoint on pages 1706-7, this issue.] Cancer 1997; 80:1708-16. © 1997 American Cancer Society.Keywords
This publication has 61 references indexed in Scilit:
- Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breastEuropean Journal Of Cancer, 1995
- Pathologic correlates of prognosis in lymph node-positive breast carcinomasCancer, 1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictorCancer, 1991
- Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapyCancer, 1990
- Tumor grade as a prognostic factor in primary breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Combination Adjuvant Chemotherapy for Node-Positive Breast CancerNew England Journal of Medicine, 1988
- Steroid receptors and prognosis in operable (stage I and II) breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Pathologic findings from the national surgical adjuvant breast project.VIII. Relationship of chemotherapeutic responsiveness to tumor differentiationCancer, 1983